Search

everythinglearnresearchcommunity

for

Search:↓

Dieckol from Ecklonia cava may help hair growth and could be a potential hair loss treatment.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Ishige sinicola, a type of seaweed, may help hair grow by blocking a hair loss-related enzyme and boosting important cell growth.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Certain transporters are found in human hair follicles and may affect hair growth and loss.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Hair restoration surgery can lead to swelling, infections, scarring, numbness, hiccups, and poor hair growth.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

More research is needed to determine if iron deficiency causes hair loss.

Compounds from Angelica koreana roots, especially osthenol, could be effective for treating conditions like prostate disease and hair loss.

Platelet-rich plasma (PRP) treatment has been found effective in promoting hair growth for alopecia patients, with minimal side effects like temporary pain and redness.

Nano-sized lipid particles increase dexamethasone's skin penetration and create a reservoir in the skin layers.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

First Korean case of Cronkhite-Canada syndrome with colon cancer and serrated adenoma.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.